Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy
Titel:
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy
Auteur:
Lefebvre, C. Martin, E. Hendriks, L.E.L. Veillon, R. Puisset, F. Mezquita, L. Ferrara, R. Sabatier, M. Filleron, T. Dingemans, A.-M.C. Besse, B. Raherisson, C. Mazières, J.